Gastrointestinal Oncology Program

HOSPITAL

University Hospitals Seidman Cancer Center

KEY CONTACTS

Advanced Endoscopics

Andrew Catanzaro, MD
Amitabh Chak, MD
Fazel Dinary, MD
John Dumot, DO
Ashley Faulx, MD
Umar Hayat, MD
Gerald Isenberg, MD
Omar Sadiq, MD

Medical Oncology 

David Bajor, MD
Saki Chakrabarti, MD
Madison Conces, MD
Melisaa Lumish, MD
Amit Mahipal, MD
Amr Mohamed, MD

Radiation Oncology

Jennifer Dorth, MD
Lauren Henke, MD
Ellen Wiegner, MD 

Surgery | HPB 

Ammori, MD
Jeffrey Hardacre, MD
Richard Hoehn, MD
Jordan Winter, MD

Surgery | Thoracic

Boxiang Jiang, MD
Philip Linden, MD
Jillian Sinopoli, MD
Leonidas Tapias, MD
Christopher Towe, MD

CRC

Meagan Costedio, MD
Ronald Charles, MD
Michael Liu, MD
Jill Peysha, MD
Emily Steinhagen, MD
Trevor Teetor, MD

APPOINTMENT LINE

UH Seidman Cancer Center | 440-732-4277.
For hospital transfers, please call 216-844-1111.

Conditions Treated
Esophagogastric cancers, including Barrett’s esophagus
Biliary cancers
Pancreatic cancers: pancreatic adenocarcinoma, pancreatic cystic neoplasms,pancreatic neuroendocrine tumors and rare pancreatic tumors
Small intestinal cancers
Colorectal cancers
Anal cancers
Gastrointestinal stromal tumors
Neuroendocrine cancers

Procedures and Therapies
Endoscopic ultrasound, endoscopic mucosal resection and submucosal dissection for the staging treatment of early esophageal cancers
Noninvasive treatments (stenting, robotic and laparoscopic procedures, transanal resections)
Liver-directed therapies, including resection of metastases, surgical ablation, transarterial chemoembolization, radioembolization and percutaneous microwave ablation
Colo-anal reconstruction/sphincter-sparing surgery
Enhanced recovery programs following colorectal surgery
Radiation therapy, including proton beam therapy, IMRT and MR planning, and intraoperative radiation
Chemotherapy and immunotherapy, including clinical trials

Distinguishing Features
Part of NCI-designated Case Comprehensive Cancer Center
Multidisciplinary consultation and disease-specific tumor boards
First in Northeast Ohio to perform minimally invasive esophagectomy
Lowest esophagectomy mortality rate in the nation
One of three NCI Barrett’s Esophagus Translational Research Network centers, via Case Western Reserve University
Innovative clinical trials of new treatments
One of six National Cancer Institute Specialized Programs of Research Excellence (SPORE) centers for gastrointestinal cancers in the U.S., via Case Western Reserve University
National leadership in clinical pathway development
Noninvasive diagnostic technology using new imaging methodologies
Only Proton Therapy Center in Ohio
Genetic analysis of tumors to guide personalized therapy
Genetic risk assessment to guide preventive strategies in cancer-prone families
Supportive and Integrative Oncology program
Specialized Adolescent and Young Adult (AYA) cancer program